Sign in

NCT05674942Completed

Urinary Tract Infection in Patients With Chronic Kidney Disease

Urinary Tract Infection in Patients With Chronic Kidney Disease: A Retrospective Observational Study at Outpatient Nephrology Clinics

Source: ClinicalTrials.gov · Last updated 18 Jun 2024

Brief summary (registry, in English)

This study aims to investigate the etiology and associated risk factors for UTI in Egyptian chronic kidney disease patients. In addition, to identify the isolated micro-organisms and their sensitivity patterns for better anticipation of treatment regimen.

Status (registry)
Completed
Study type
Observational
Enrollment
250 (actual)
First submitted
14 Dec 2022
Start date
1 Jun 2023
Primary completion date
15 Apr 2024
Lead sponsor
Alexandria University
NCT number
NCT05674942

What you commit to

  • Study type: Observational
  • Participants enrolled: 250
  • From 1 Jun 2023 to the primary completion date, 15 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Non-CKD patients
  • pregnant females
  • CKD patients on immunosuppressant agents
  • ESRD patients on hemodialysis
  • Patients with structural abnormalities which make them liable to frequent UTI

Who the study is looking for

  • Males and non-pregnant females aged ≥ 18 years old
  • Patients with CKD stages (G1 to G4)
  • Patients diagnosed with UTI due to urine culture

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Faculty of Medicine, Alexandria University
Coordinator of this site? Confirm its status
AlexandriaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.